PuraPharm Corporation Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	12.23	16.17	12.79	20.13	75.83	59.67
Short-Term Investments	-	19.73	24.1	22.85	15.53	36.39
Cash & Short-Term Investments	12.23	35.9	36.9	42.98	91.36	96.06
Cash Growth	-27.21%	-2.72%	-14.14%	-52.96%	-4.89%	-27.53%
Accounts Receivable	44.38	56.41	57.5	80.87	131.87	261.41
Other Receivables	-	5.24	7.09	8.77	8.5	2.25
Receivables	44.38	61.64	64.59	89.64	140.37	263.65
Inventory	108.89	99.19	123.56	175.6	190.81	199.8
Prepaid Expenses	51.95	21.84	14.25	10.19	26.69	23.56
Restricted Cash	-	0.01	0.01	27.1	31.18	25.38
Other Current Assets	-	8.51	29.14	4.08	5.58	2.41
Total Current Assets	217.44	227.09	268.44	349.57	486	610.86
Property, Plant & Equipment	365.18	352.72	355.39	396.91	431.08	461.02
Long-Term Investments	15.76	3.61	3.7	2.96	1.2	-
Goodwill	17.94	17.94	17.94	17.94	20.99	20.99
Other Intangible Assets	65.32	67	31.56	34.74	37.64	41.06
Long-Term Deferred Tax Assets	7.31	6.87	7.7	8.82	11.05	10.48
Other Long-Term Assets	10.86	18.53	30.99	33.03	28.54	61.45
Total Assets	699.82	693.76	715.73	843.96	1,016	1,206

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	84.19	85.23	132.21	146.38	137.91	140.68
Short-Term Debt	-	60.29	134.76	250.8	353.7	362.05
Current Portion of Long-Term Debt	272.83	208.02	115.79	53.22	56.44	45.62
Current Portion of Leases	15.37	15.81	13.63	17.97	18.51	13.24
Current Income Taxes Payable	2.15	3.52	7.71	2.07	1.44	3.58
Current Unearned Revenue	0.17	0.17	0.17	0.17	0.25	2.34
Other Current Liabilities	99.57	106.38	86.8	100.48	97.16	97.81
Total Current Liabilities	474.28	479.42	491.07	571.09	665.41	665.31
Long-Term Debt	61.08	55.51	89.16	81.09	48.68	92
Long-Term Leases	21.34	11.52	10.42	21.68	25.83	19.05
Long-Term Unearned Revenue	3.08	2.69	1.9	1.08	1.03	1.17
Long-Term Deferred Tax Liabilities	2.68	2.2	0.97	1.74	3.02	2.61
Other Long-Term Liabilities	12.41	11.96	11.02	14.04	14.25	24.16
Total Liabilities	574.86	563.27	604.53	690.73	758.21	804.31

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	4.15	4.15	306.82	306.82	306.82	306.04
Additional Paid-In Capital	-	280.69	221.57	221.57	221.57	221.19
Retained Earnings	-	-125.6	-394.13	-358.69	-252.63	-133.03
Comprehensive Income & Other	120.81	-28.76	-23.06	-16.47	-17.47	7.36
Shareholders' Equity	124.96	130.48	111.2	153.24	258.29	401.56
Total Liabilities & Equity	699.82	693.76	715.73	843.96	1,016	1,206

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	370.62	351.14	363.76	424.77	503.16	531.96
Net Cash (Debt)	-358.39	-315.25	-326.86	-381.8	-411.8	-435.9
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.73	-0.75	-0.83	-0.97	-1.04	-1.11
Filing Date Shares Outstanding	535.49	535.05	395.05	395.05	395.05	393.93
Total Common Shares Outstanding	535.49	535.05	395.05	395.05	395.05	393.93
Working Capital	-256.84	-252.33	-222.63	-221.52	-179.41	-54.46
Book Value Per Share	0.23	0.24	0.28	0.39	0.65	1.02
Tangible Book Value	41.7	45.54	61.69	100.55	199.66	339.5
Tangible Book Value Per Share	0.08	0.09	0.16	0.25	0.51	0.86
Land	-	222.9	218.08	225.23	225.13	234.75
Machinery	-	207.16	197.51	204.33	203.97	203.05
Construction In Progress	-	70.59	68.99	69.18	71.28	77.66
Leasehold Improvements	-	27.86	29.76	15.7	16.51	24.31